|
Clinical Pharmacology
CLINICAL PHARMACOLOGY
The therapeutic effects of Diltiazem Hydrochloride Extended-release Capsules USP (once-a-day dosage) are believed to be related to its ability to inhibit the influx of calcium ions during membrane depolarization of cardiac and vascular smooth muscle. Mechanisms of Action Hypertension Text Continues Below
Diltiazem Hydrochloride Extended-release Capsules USP (once-a-day dosage) produces its antihypertensive effect primarily by relaxation of vascular smooth muscle and the resultant decrease in peripheral vascular resistance. The magnitude of blood pressure reduction is related to the degree of hypertension; thus hypertensive individuals experience an antihypertensive effect, whereas there is only a modest fall in blood pressure in normotensives. Angina Diltiazem Hydrochloride Extended-release Capsules USP (once-a-day dosage) has been shown to produce increases in exercise tolerance, probably due to its ability to reduce myocardial oxygen demand. This is accomplished via reductions in heart rate and systemic blood pressure at submaximal and maximal work loads. Diltiazem has been shown to be a potent dilator of coronary arteries, both epicardial and subendocardial. Spontaneous and ergonovine-induced coronary artery spasm are inhibited by diltiazem. In animal models, diltiazem interferes with the slow inward (depolarizing) current in excitable tissue. It causes excitation-contraction uncoupling in various myocardial tissues without changes in the configuration of the action potential. Diltiazem produces relaxation of coronary vascular smooth muscle and dilation of both large and small coronary arteries at drug lev-els which cause little or no negative inotropic effect. The resultant increases in coronary blood flow (epicardial and suben-docardial) occur in ischemic and nonischemic models and are accompanied by dose-dependent decreases in systemic blood pressure and decreases in peripheral resistance. Page: 1 | 2 | 3 | 4 | 5 | Next >>
|
